
[ Mon, Oct 31st 2011 ]: Market Wire
[ Mon, Oct 31st 2011 ]: Market Wire

[ Sat, Oct 29th 2011 ]: Market Wire

[ Fri, Oct 28th 2011 ]: Market Wire
[ Fri, Oct 28th 2011 ]: Market Wire
[ Fri, Oct 28th 2011 ]: Market Wire
[ Fri, Oct 28th 2011 ]: Market Wire
[ Fri, Oct 28th 2011 ]: Market Wire
[ Fri, Oct 28th 2011 ]: Market Wire
[ Fri, Oct 28th 2011 ]: Market Wire
[ Fri, Oct 28th 2011 ]: Market Wire
[ Fri, Oct 28th 2011 ]: Market Wire
[ Fri, Oct 28th 2011 ]: Market Wire
[ Fri, Oct 28th 2011 ]: Market Wire
[ Fri, Oct 28th 2011 ]: Market Wire
[ Fri, Oct 28th 2011 ]: Market Wire
[ Fri, Oct 28th 2011 ]: Market Wire
[ Fri, Oct 28th 2011 ]: Market Wire

[ Thu, Oct 27th 2011 ]: Market Wire
[ Thu, Oct 27th 2011 ]: Market Wire
[ Thu, Oct 27th 2011 ]: Market Wire
[ Thu, Oct 27th 2011 ]: Market Wire
[ Thu, Oct 27th 2011 ]: Market Wire
[ Thu, Oct 27th 2011 ]: Market Wire
[ Thu, Oct 27th 2011 ]: Market Wire
[ Thu, Oct 27th 2011 ]: Market Wire
[ Thu, Oct 27th 2011 ]: Market Wire
[ Thu, Oct 27th 2011 ]: Market Wire
[ Thu, Oct 27th 2011 ]: Market Wire
[ Thu, Oct 27th 2011 ]: Market Wire
[ Thu, Oct 27th 2011 ]: Market Wire
[ Thu, Oct 27th 2011 ]: Market Wire
[ Thu, Oct 27th 2011 ]: Market Wire

[ Wed, Oct 26th 2011 ]: Market Wire
[ Wed, Oct 26th 2011 ]: Market Wire
[ Wed, Oct 26th 2011 ]: Market Wire
[ Wed, Oct 26th 2011 ]: Market Wire
[ Wed, Oct 26th 2011 ]: Market Wire
[ Wed, Oct 26th 2011 ]: Market Wire
[ Wed, Oct 26th 2011 ]: Market Wire
[ Wed, Oct 26th 2011 ]: Market Wire
[ Wed, Oct 26th 2011 ]: Market Wire
[ Wed, Oct 26th 2011 ]: Market Wire
[ Wed, Oct 26th 2011 ]: Market Wire
[ Wed, Oct 26th 2011 ]: Market Wire
[ Wed, Oct 26th 2011 ]: Market Wire
[ Wed, Oct 26th 2011 ]: Market Wire
[ Wed, Oct 26th 2011 ]: Market Wire
Biogen Idec y Portola Pharmaceuticals anuncian colaboracin global para el programa Syk oral para el tratamiento de enfermedades


🞛 This publication is a summary or evaluation of another publication
WESTON, Mass. & SOUTH SAN FRANCISCO, California--([ BUSINESS WIRE ])--[ Biogen Idec ] (NASDAQ: BIIB) y [ Portola Pharmaceuticals, Inc. ] han anunciado que han firmado un acuerdo de colaboracin y licencia mundial por el que ambas empresas desarrollarn y comercializarn inhibidores oral nuevos muy selectivos Syk para el tratamiento de varias enfermedades autoinmunes e inflamatorias, incluidas la artritis reumatoide y el lupus sistmico eritematoso.
El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.